Literature DB >> 25939604

Circulating Lipocalin 2 Levels Predict Fracture-Related Hospitalizations in Elderly Women: A Prospective Cohort Study.

Wai H Lim1,2, Germaine Wong3, Ee M Lim4,5, Elizabeth Byrnes5, Kun Zhu1,5, Amanda Devine6, Nathan J Pavlos7, Richard L Prince1,5, Joshua R Lewis1,5.   

Abstract

Lipocalin 2 (LCN2) or neutrophil gelatinase-associated lipocalin (NGAL) is expressed in a wide range of cells and pathological states. Mounting evidence suggests lipocalin 2 may be an important regulator of bone homeostasis. Recently it has been suggested LCN2 is a novel mechanoresponsive gene central to the pathological response to low mechanical force. We undertook a prospective study of 1009 elderly women over 70 years of age to study the association between circulating LCN2 and potential associated variables, including estimated glomerular filtration rate, physical activity, and baseline measures of hip bone density and heel bone quality. Osteoporotic fractures requiring hospitalizations were identified from the Western Australian Data Linkage System. Over 14.5 years, 272 (27%) of women sustained an osteoporotic fracture-related hospitalization; of these, 101 were hip fractures. Circulating LCN2 levels were correlated with body mass index and estimated glomerular filtration rate (r = 0.249, p < 0.001 and r = -0.481, p < 0.001, respectively) that modified the association with hip and heel bone measures. Per standard deviation increase in LCN2, there was a 30% multivariable-adjusted increase in the risk of any osteoporotic fracture (hazard ratio [HR] = 1.30, 95% confidence interval [CI] 1.13-1.50, p < 0.001). In participants with elevated LCN2 levels above the median (76.6 ng/mL), there was an 80% to 81% increase in the risk of any osteoporotic or hip fracture (HR = 1.81, 95% CI 1.38-2.36, p < 0.001 and HR = 1.80, 95% CI 1.16-2.78, p = 0.008, respectively). These associations remained significant after adjustment for total hip bone mineral density (p < 0.05). In conclusion, we have demonstrated that circulating LCN2 levels predict future risk of osteoporotic fractures requiring hospitalization. Measurement of LCN2 levels may improve fracture prediction in addition to current fracture risk factors in the elderly, particularly in those with impaired renal function.
© 2015 American Society for Bone and Mineral Research.

Entities:  

Keywords:  ELDERLY WOMEN; FRACTURE RISK; LCN2; NGAL; OSTEOPOROSIS; PHYSICAL ACTIVITY

Mesh:

Substances:

Year:  2015        PMID: 25939604     DOI: 10.1002/jbmr.2546

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  10 in total

1.  The relationship among serum lipocalin 2, bone turnover markers, and bone mineral density in outpatient women.

Authors:  Dong-Mei Liu; Hong-Yan Zhao; Lin Zhao; Min-Jia Zhang; Ting-Ting Liu; Bei Tao; Li-Hao Sun; Jian-Min Liu
Journal:  Endocrine       Date:  2018-01-02       Impact factor: 3.633

2.  Association of plasma neutrophil gelatinase-associated lipocalin with parameters of CKD-MBD in maintenance hemodialysis patients.

Authors:  Xiao-Yan Jia; Kai Wei; Juan Chen; Lin-He Xi; Xiang-Lei Kong; Yong Wei; Li Wang; Zun-Song Wang; Yi-Peng Liu; Li-Ming Liang; Dong-Mei Xu
Journal:  J Bone Miner Metab       Date:  2021-08-15       Impact factor: 2.626

Review 3.  Lipocalin-2: a novel link between the injured kidney and the bone.

Authors:  Guillaume Courbon; Valentin David
Journal:  Curr Opin Nephrol Hypertens       Date:  2022-07-01       Impact factor: 3.416

Review 4.  Impact of Chronic Inflammation in Psoriasis on Bone Metabolism.

Authors:  Anja Saalbach; Manfred Kunz
Journal:  Front Immunol       Date:  2022-06-23       Impact factor: 8.786

5.  Lipocalin 2 serum levels correlate with age and bone turnover biomarkers in healthy subjects but not in postmenopausal osteoporotic women.

Authors:  Antonio Maurizi; Marco Ponzetti; Kaare M Gautvik; Sjur Reppe; Anna Teti; Nadia Rucci
Journal:  Bone Rep       Date:  2021-03-29

6.  The adipokine lipocalin-2 in the context of the osteoarthritic osteochondral junction.

Authors:  Amanda Villalvilla; Adela García-Martín; Raquel Largo; Oreste Gualillo; Gabriel Herrero-Beaumont; Rodolfo Gómez
Journal:  Sci Rep       Date:  2016-07-07       Impact factor: 4.379

7.  Osteoporosis in Patients with Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome.

Authors:  Jee Youn Oh; Young Seok Lee; Kyung Hoon Min; Sung Yong Lee; Jae Jeong Shim; Kyung Ho Kang; Gyu Young Hur
Journal:  Tuberc Respir Dis (Seoul)       Date:  2017-11-27

8.  Calcaneal quantitative ultrasound is associated with all-cause and cardiovascular disease mortality independent of hip bone mineral density.

Authors:  A K Gebre; R L Prince; J T Schousboe; D P Kiel; P L Thompson; K Zhu; W H Lim; M Sim; J R Lewis
Journal:  Osteoporos Int       Date:  2022-02-11       Impact factor: 5.071

9.  Lipocalin-2 is associated with FGF23 in WNT1 and PLS3 osteoporosis.

Authors:  Petra Loid; Helena Hauta-Alus; Outi Mäkitie; Per Magnusson; Riikka E Mäkitie
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-08       Impact factor: 6.055

10.  Influence of bone mineral density in circulating adipokines among postmenopausal Arab women.

Authors:  Mohammed Ghouse Ahmed Ansari; Syed Danish Hussain; Kaiser Ahmed Wani; Sobhy M Yakout; Dara Al-Disi; Majed S Alokail; Jean-Yves Reginster; Nasser M Al-Daghri
Journal:  Saudi J Biol Sci       Date:  2019-10-31       Impact factor: 4.219

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.